Associated Papers
Clinical significance of FBXW7 loss of function in human cancers.
Fan J et al.
Molecular Cancer, 2022
PSEN1-selective gamma-secretase inhibition in combination with kinase or XPO-1 inhibitors effectively targets T cell acute lymphoblastic leukemia.
Govaerts I et al.
Journal of Hematology & Oncology, 2021
34167562 (PubMed )
Supplement: 13045_2021_1114_MOESM1_ESM.xlsx › Sheet1
Loss of FBXW7-mediated degradation of BRAF elicits resistance to BET inhibitors in adult T cell leukemia cells.
Yeh CH et al.
Molecular Cancer, 2020
Development and validation of a targeted gene sequencing panel for application to disparate cancers.
McCabe MJ et al.
Scientific Reports, 2019
31745186 (PubMed )
Supplement: 41598_2019_52000_MOESM2_ESM.xlsx › Sheet1
FBXW7: a critical tumor suppressor of human cancers.
Yeh CH et al.
Molecular Cancer, 2018
Oncogenic mutations in the FBXW7 gene of adult T-cell leukemia patients.
Yeh CH et al.
Proceedings of the National Academy of Sciences of the United States of America, 2016
Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers.
Maser RS et al.
Nature, 2007
Select a paper to view details